Fusion polypeptides, and use thereof in antivascular tumor therapy

Details for Australian Patent Application No. 2004268031 (hide)

Owner Oncoscience AG Berdel, W. Bizimis, A.

Inventors Berdel, Wolfgang E.; Mesters, Rolf M.

Agent Shelston IP

Pub. Number AU-B-2004268031

PCT Pub. Number WO2005/021593

Priority 103 38 733.1 22.08.03 DE

Filing date 20 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 3 September 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/021593 Priority application(s): WO2005/021593

3 September 2009 Application Accepted

  Published as AU-B-2004268031

7 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268040-Delta15-D-homosteroids having an androgenic effect

2004268024-Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor